Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Click Us!
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Thickeners and Stabilizers
Parenteral
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Belinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Belinostat, including repackagers and relabelers. The FDA regulates Belinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Belinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Belinostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Belinostat supplier is an individual or a company that provides Belinostat active pharmaceutical ingredient (API) or Belinostat finished formulations upon request. The Belinostat suppliers may include Belinostat API manufacturers, exporters, distributors and traders.
click here to find a list of Belinostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Belinostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Belinostat active pharmaceutical ingredient (API) in detail. Different forms of Belinostat DMFs exist exist since differing nations have different regulations, such as Belinostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Belinostat DMF submitted to regulatory agencies in the US is known as a USDMF. Belinostat USDMF includes data on Belinostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Belinostat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Belinostat suppliers with USDMF on PharmaCompass.
A Belinostat written confirmation (Belinostat WC) is an official document issued by a regulatory agency to a Belinostat manufacturer, verifying that the manufacturing facility of a Belinostat active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Belinostat APIs or Belinostat finished pharmaceutical products to another nation, regulatory agencies frequently require a Belinostat WC (written confirmation) as part of the regulatory process.
click here to find a list of Belinostat suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Belinostat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Belinostat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Belinostat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Belinostat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Belinostat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Belinostat suppliers with NDC on PharmaCompass.
Belinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Belinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Belinostat GMP manufacturer or Belinostat GMP API supplier for your needs.
A Belinostat CoA (Certificate of Analysis) is a formal document that attests to Belinostat's compliance with Belinostat specifications and serves as a tool for batch-level quality control.
Belinostat CoA mostly includes findings from lab analyses of a specific batch. For each Belinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Belinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Belinostat EP), Belinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Belinostat USP).
LOOKING FOR A SUPPLIER?
Comment (2)
